trial · primary record
Anti-ICOS Monoclonal Antibody MEDI-570
Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 21 |
| Primary completion | 2026-12-24 |
| Primary endpoint | Incidence of toxicity and safety of anti-inducible T-cell co-stimulator (ICOS) monoclonal antibody MEDI-570 |
| Registry ID | NCT02520791 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:20.513Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02520791
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.